CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals.  Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue.  We also offer solutions that can help ease private company financial risk assessment.  Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively. 

A partial report preview for Profusa Inc is shown below.  Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database.  To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

Profusa Inc
207 West 25Th St, 9Th Floor
Phone: (212) 494-9022p:212 494-9022 NEW YORK, NY  10001  United States Ticker: PFSAPFSA
Business Summary
Profusa, Inc. is a digital health company developing tissue-integrated sensors to detect and continuously transmit actionable, medical-grade data for personal and medical use. With its injectable and biosensors and its intelligent data platform, the Company is focused on providing people with a personalized biochemical signature. Its offering in the European Union, the Lumee Oxygen Platform, monitors tissue oxygen levels and is intended for applications such as peripheral artery disease, chronic wounds (including diabetic ulcers and pressure sores), and reconstructive surgery. Its research and development efforts are primarily focused on the Lumee Glucose Platform, a continuous glucose monitor (CGM) consisting of a biocompatible gel injected under the skin that monitors interstitial glucose levels for several months from a single injection. Its Data Discovery Platform, built on NVIDIA AI, transforms the continuous stream of biochemical sensor data into personalized clinical insights.
(Source: Company's Website)

Scores and Ratings
FRISK®
Score		 Z''
Score		 PAYCE®
Score		 DBT
Index		 Moody's
Rating		 Fitch
Rating		 DBRS
Rating
YesYes-----

Financials, News and Filings
Latest
Statement		 Last
Audit
News		 SEC
Filings		 Bankruptcy
Filings		 Suit &
Judgment
Filings		 Tax
Lien
Filings
9/30/202512/31/2024YesYesYes-Yes

Industries
SIC Code Description
3841 Surgical and medical instruments and apparatus
3845 Electromedical and electrotherapeutic apparatus

Officers and Directors

Title
Name
Age		 Title
Date		 Start
Date
Executive Chairman of the Board, Chief Executive Officer Jack E.Stover 69 7/21/2026 4/19/2021
Chief Financial Officer FredKnechtel 63 7/11/2025 4/19/2021
Lead Independent Director PeterO'Rourke 53 7/11/2025 12/20/2021
3 additional Officers and Directors records available in full report.

Business Names
Business Name
New Profusa, Inc.
NVAC
NVACU
PFSA

General Information
Outstanding Shares: 605,647 (As of 8/18/2026)
Shareholders: 4
Stock Exchange: NASD
Federal Tax Id: 863437271
Fax Number: (302) 636-5454


Copyright © 2026 CreditRiskMonitor.com (Ticker: CRMZ). All rights reserved.     
By using this website, you accept the Terms of Use Agreement.
Tuesday, October 6, 2026